• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生理应激时优化心脏再同步治疗起搏模式的改变。

Changes in the optimal cardiac resynchronization therapy pacing configuration during physiologic stress.

机构信息

Division of Cardiology, Duke University School of Medicine, Durham, NC, USA; Division of Cardiology, Durham VA Medical Center, Durham, NC, USA.

Division of Cardiology, Duke University School of Medicine, Durham, NC, USA; Division of Cardiology, Durham VA Medical Center, Durham, NC, USA.

出版信息

J Electrocardiol. 2020 Sep-Oct;62:124-128. doi: 10.1016/j.jelectrocard.2020.08.012. Epub 2020 Aug 19.

DOI:10.1016/j.jelectrocard.2020.08.012
PMID:32866910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7666003/
Abstract

BACKGROUND

Some patients with ongoing heart failure symptoms after treatment with cardiac resynchronization therapy (CRT) demonstrate QRS prolongation during exercise. We investigated whether the optimal CRT pacing configuration changes during dobutamine stress.

METHODS

Seven patients undergoing CRT implantation underwent invasive LV dP/dT measurement during CRT pacing in 10 configurations to determine the optimal baseline pacing configuration (OPC). Measurements were repeated during dobutamine infusion. Differences in mean LV dP/dT between pacing configurations were compared.

RESULTS

Baseline OPC differed from stress OPC in 6/7 patients. The mean (SD) LV dP/dT obtained during dobutamine infusion was 1140 (377) mmHg/s in AAI pacing, 1458 (448) mmHg/s in the baseline OPC, and 1656 (435) mmHg/s in the dobutamine OPC (p < 0.001 for differences). The mean increase in LV dP/dT obtained by changing from baseline OPC to dobutamine OPC during dobutamine infusion was 197 (338) mmHg/s (13%). The QRS duration, QRS morphology, QLV and QRV intervals did not change significantly during dobutamine infusion (all P > 0.05).

CONCLUSIONS

The optimal CRT pacing configuration changes during dobutamine infusion while LV and RV activation timing does not. Further studies investigating the usefulness of automated dynamic changes to CRT pacing configuration according to physiologic condition may be warranted.

摘要

背景

一些接受心脏再同步治疗(CRT)后仍有心衰症状的患者在运动时表现出 QRS 波延长。我们研究了在多巴酚丁胺应激期间是否改变了最佳 CRT 起搏配置。

方法

7 名接受 CRT 植入的患者在 10 种起搏配置下进行 CRT 起搏时进行了左心室 dp/dt 测量,以确定最佳基线起搏配置(OPC)。在多巴酚丁胺输注期间重复测量。比较了不同起搏配置之间的平均左心室 dp/dt 差异。

结果

6/7 名患者的基线 OPC 与应激 OPC 不同。在 AAI 起搏时,多巴酚丁胺输注期间获得的平均(SD)左心室 dp/dt 为 1140(377)mmHg/s,在基线 OPC 时为 1458(448)mmHg/s,在多巴酚丁胺 OPC 时为 1656(435)mmHg/s(差异均 p<0.001)。在多巴酚丁胺输注期间,从基线 OPC 改变为多巴酚丁胺 OPC 时,左心室 dp/dt 的平均增加量为 197(338)mmHg/s(13%)。在多巴酚丁胺输注期间,QRS 持续时间、QRS 形态、QLV 和 QRV 间隔没有明显变化(均 P>0.05)。

结论

在多巴酚丁胺输注期间,最佳 CRT 起搏配置发生变化,而 LV 和 RV 激活时间不变。可能需要进一步研究根据生理状况自动动态改变 CRT 起搏配置的有用性。

相似文献

1
Changes in the optimal cardiac resynchronization therapy pacing configuration during physiologic stress.生理应激时优化心脏再同步治疗起搏模式的改变。
J Electrocardiol. 2020 Sep-Oct;62:124-128. doi: 10.1016/j.jelectrocard.2020.08.012. Epub 2020 Aug 19.
2
Determinants of LV dP/dt and QRS duration with different fusion strategies in cardiac resynchronisation therapy.不同心脏再同步治疗融合策略对左心室 dp/dt 和 QRS 持续时间的影响因素。
Open Heart. 2021 May;8(1). doi: 10.1136/openhrt-2021-001615.
3
Acute biventricular hemodynamic effects of cardiac resynchronization therapy in right bundle branch block.心脏再同步治疗对右束支传导阻滞患者双心室血液动力学的急性影响。
Heart Rhythm. 2018 Oct;15(10):1525-1532. doi: 10.1016/j.hrthm.2018.05.017. Epub 2018 May 23.
4
Haemodynamic effects of cardiac resynchronization therapy using single-vein, three-pole, multipoint left ventricular pacing in patients with ischaemic cardiomyopathy and a left ventricular free wall scar: the MAESTRO study.缺血性心肌病伴左心室游离壁瘢痕患者应用单静脉、三极、多点左心室起搏的心脏再同步治疗的血液动力学效应:MAESTRO 研究。
Europace. 2016 Aug;18(8):1227-34. doi: 10.1093/europace/euv396. Epub 2015 Dec 30.
5
Body surface mapping using an ECG belt to characterize electrical heterogeneity for different left ventricular pacing sites during cardiac resynchronization: Relationship with acute hemodynamic improvement.使用心电图带进行体表标测以表征心脏再同步治疗期间不同左心室起搏部位的电不均一性:与急性血流动力学改善的关系
Heart Rhythm. 2017 Mar;14(3):385-391. doi: 10.1016/j.hrthm.2016.11.017. Epub 2016 Nov 18.
6
Determination of the longest intrapatient left ventricular electrical delay may predict acute hemodynamic improvement in patients after cardiac resynchronization therapy.测定最长的患者内左心室电延迟时间可能预测心脏再同步治疗后患者的急性血液动力学改善。
Circ Arrhythm Electrophysiol. 2014 Jun;7(3):377-83. doi: 10.1161/CIRCEP.113.000850. Epub 2014 Mar 25.
7
Multipoint pacing by a left ventricular quadripolar lead improves the acute hemodynamic response to CRT compared with conventional biventricular pacing at any site.与在任何部位进行的传统双心室起搏相比,使用左心室四极导线进行多点起搏可改善对心脏再同步治疗的急性血流动力学反应。
Heart Rhythm. 2015 May;12(5):975-81. doi: 10.1016/j.hrthm.2015.01.034. Epub 2015 Jan 24.
8
The effect of left ventricular electrical delay on the acute hemodynamic response with cardiac resynchronization therapy.左心室电延迟对心脏再同步治疗急性血流动力学反应的影响。
J Cardiovasc Electrophysiol. 2014 Jun;25(6):624-30. doi: 10.1111/jce.12372. Epub 2014 Feb 13.
9
Impact of pacing site on QRS duration and its relationship to hemodynamic response in cardiac resynchronization therapy for congestive heart failure.起搏部位对充血性心力衰竭心脏再同步治疗中QRS时限的影响及其与血流动力学反应的关系。
J Cardiovasc Electrophysiol. 2014 Sep;25(9):1012-1020. doi: 10.1111/jce.12464. Epub 2014 Jul 24.
10
Vector selection of a quadripolar left ventricular pacing lead affects acute hemodynamic response to cardiac resynchronization therapy: a randomized cross-over trial.四极左心室起搏导线的向量选择对心脏再同步治疗急性血液动力学反应的影响:一项随机交叉试验。
PLoS One. 2013 Jun 24;8(6):e67235. doi: 10.1371/journal.pone.0067235. Print 2013.

本文引用的文献

1
Frequency and causes of QRS prolongation during exercise electrocardiogram testing in biventricular paced patients with heart failure.心力衰竭双心室起搏患者运动心电图测试期间QRS波增宽的频率及原因
HeartRhythm Case Rep. 2020 May 7;6(6):308-312. doi: 10.1016/j.hrcr.2020.02.006. eCollection 2020 Jun.
2
Vectorcardiographic QRS area is associated with long-term outcome after cardiac resynchronization therapy.心向量心电图 QRS 面积与心脏再同步治疗后的长期预后相关。
Heart Rhythm. 2019 Feb;16(2):213-219. doi: 10.1016/j.hrthm.2018.08.028. Epub 2018 Aug 28.
3
Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead?
能否利用固有左心室延迟(QLV)优化具有四极左心室导线的心脏再同步治疗的起搏配置?
Circ Arrhythm Electrophysiol. 2018 Mar;11(3):e005912. doi: 10.1161/CIRCEP.117.005912.
4
Left Ventricular Lead Electrical Delay Is a Predictor of Mortality in Patients With Cardiac Resynchronization Therapy.左心室导线电延迟是心脏再同步治疗患者死亡率的一个预测指标。
Circ Arrhythm Electrophysiol. 2015 Oct;8(5):1113-21. doi: 10.1161/CIRCEP.115.003004. Epub 2015 Sep 3.
5
Cardiac resynchronization therapy: state-of-the-art of current applications, guidelines, ongoing trials, and areas of controversy.心脏再同步治疗:当前应用的最新进展、指南、正在进行的试验及争议领域。
Circulation. 2013 Nov 26;128(22):2407-18. doi: 10.1161/CIRCULATIONAHA.112.000112.
6
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会实践指南工作组关于心力衰竭管理的指南:美国心脏病学会基金会/美国心脏协会报告
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. doi: 10.1016/j.jacc.2013.05.019. Epub 2013 Jun 5.
7
Acute effects of levosimendan and dobutamine on QRS duration in patients with heart failure.左西孟旦和多巴酚丁胺对心力衰竭患者 QRS 时限的急性影响。
Arq Bras Cardiol. 2010 Dec;95(6):738-42. doi: 10.1590/s0066-782x2010005000143. Epub 2010 Nov 12.
8
Analysis of ventricular activation using surface electrocardiography to predict left ventricular reverse volumetric remodeling during cardiac resynchronization therapy.应用体表心电图分析心室激动预测心脏再同步治疗期间左心室逆向容积重构。
Circulation. 2010 Feb 9;121(5):626-34. doi: 10.1161/CIRCULATIONAHA.109.894774. Epub 2010 Jan 25.
9
Cardiac-resynchronization therapy for the prevention of heart-failure events.心脏再同步治疗预防心力衰竭事件
N Engl J Med. 2009 Oct 1;361(14):1329-38. doi: 10.1056/NEJMoa0906431. Epub 2009 Sep 1.
10
Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.轻度症状性心力衰竭患者以及无症状左心室功能不全且既往有心力衰竭症状患者心脏再同步化治疗的随机试验。
J Am Coll Cardiol. 2008 Dec 2;52(23):1834-1843. doi: 10.1016/j.jacc.2008.08.027. Epub 2008 Nov 7.